4.3 Article

BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Oncology

Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine

Amanda J. Redig et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Oncology

Borrowing Information across Subgroups in Phase II Trials: Is It Useful?

Boris Freidlin et al.

CLINICAL CANCER RESEARCH (2013)

Article Medicine, Research & Experimental

Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials

Scott M. Berry et al.

CLINICAL TRIALS (2013)

Article Biotechnology & Applied Microbiology

Implementing personalized cancer genomics in clinical trials

Richard Simon et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Article Medicine, General & Internal

BRAF Mutations in Hairy-Cell Leukemia

Enrico Tiacci et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Oncology

Pathways of apoptotic and non-apoptotic death in tumour cells

H Okada et al.

NATURE REVIEWS CANCER (2004)

Article Mathematical & Computational Biology

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

PF Thall et al.

STATISTICS IN MEDICINE (2003)

Article Statistics & Probability

Bayesian measures of model complexity and fit

DJ Spiegelhalter et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2002)